Your Custom Text Here
Dr. Sean Ekins will be presenting on “Drug Discovery Applications of Machine Learning In a Small Company”.
Boston Marriott Newton Hotel, Boston.
https://drugdiscovery.unitedscientificgroup.org/experts
Sean Ekins will be presenting “In Silico ADME/Tox In the Generative AI Paradigm”
San Diego, CA
https://www.drugdiscoverychemistry.com
Dr’s. Thomas Lane, Fabio Urbina and Sean Ekins will be attending and presenting posters and a talk:
2002: Machine Learning and Large Language Models for Steroidogenesis, Mon, Mar 11Grand Ballroom A‚ Salt Palace Convention Center 9:45am - 10:00am (Mountain)
3312: Poster Board - P434: Inhibition Screening and Machine Learning Model Development for Equilibrative Nucleoside Transporters 9:15AM-11:15AM Mar 11 (Mountain)
4621: Poster Board - P481: In vitro Characterization and Rescue of VX Metabolism in Human Liver Microsomes, Wed, Mar 13, 11:45am - 1:45pm (Mountain) Board no. P481
Poster Board - P149: Comparison of dimensionality reduction techniques for chemical space and applicability domain determination of QSAR model training and target datasets, Wed, Mar 13, 11:45am - 1:45pm (Mountain) Board no. P149
4405: Poster Board - P192: Seizure Predictions Using Adverse Outcome Pathway-based Fast Interpretable Greedy-Tree Sums Modeling, Wed, Mar 13, 2:15pm - 4:15pm (Mountain), Board no. P192
4388: Poster Board - P175: Predicting the Activities of Selective Butyrylcholinesterase Inhibitors using Contrastive and Deep Learning Models, Wed, Mar 13, 2:15pm - 4:15pm (Mountain) Board no. P175
Sean Ekins will be presenting a talk “Applying Artificial Intelligence in a Small Drug Discovery Company”
Boston, MA.
https://www.slas.org/events-calendar/slas2024-international-conference-and-exhibition/attend/register/
Sean Ekins will be presenting a poster at this NIH/NINDS satelite meeting Nov 13th 2023 6.30-9.30pm at the Renaissance Washington, DC, Downtown Hotel (Potomac Ballroom Salon 2 and Salon 3).
Developing Treatments for Rare Diseases on a Shoestring: the Batten Disease (CLN1) Enzyme Replacement Therapy Experience
We will be presenting a poster on “Synthesis and SAR of antiviral compounds against HIV and HBV” Thane Jones, Thomas R. Lane, Vadim Makarov, Sean Ekins
Dr Sean Ekins will be presenting a poster and rapid fire presentation on “Large language models for predicting ADME/Tox” and will present in a career development session on “Winning Grants”.
Career development session Oct 23rd 12-1pm
Dr. Sean Ekins will be presenting - “A ChatGPT for drug discovery: One model versus many.”
Dr. Fabio Urbina will be presenting a talk on “Machine Learning approaches in drug discovery and repurposing”https://brisbane2023.fip.org
Dr Sean Ekins will be presenting a keynote “The Dark Side of AI: Dual Use of AI-powered Drug Discovery” focused on chemical threat issues in light of artificial intelligence developments.
Dr. Fabio Urbina will be presenting Avoiding the Dark Side of AI: From Teachable Moment and Wake Up Call to Preventing Biochemical Threats?
Cincinnati Children’s Hospital
Sean Ekins will be presenting on Machine Learning and Generative Approaches for Rare and Neglected Disease Drug Discovery
Dr. Joshua Harris will be presenting his poster “Using MegaSyn Generative Machine Learning to Identify Psychoplastogens for Opioid Abuse Treatment”
Sean Ekins is presenting “Repurposing and machine learning for COVID drug discovery”
Indianapolis, IN
Dr. Fabio Urbina will be presenting:
PAPER ID: 3825377
PAPER TITLE: “Confident predictions of blood brain barrier crossing using machine learning models with conformal predictors and applicability constraints”
DIVISION: MEDI
SESSION TYPE: Oral - In-person
Dr. Ana Puhl will be presenting in “Developing treatments for rare diseases on a shoestring: the Batten disease CLN1 experience”
Mr Scott Snyder will be presenting a poster.
Orlando, Fl
Dr. Ana Puhl will be giving a platform presentation “Developing Treatments for Rare Diseases on a Shoestring: the Batten Disease (CLN1) Enzyme Replacement Therapy Experience”
Dr Ana Puhl will be presenting at this conference.
Employing AI to Identify Potential Repurposing of Drugs to Produce Valid Candidates & Reduced Timelines in Neurology
Dr. Ana Puhl will be presenting an oral presentation “Developing Treatments for Rare Diseases on a Shoestring: the Batten Disease (CLN1) Enzyme Replacement Therapy Experience”
Dr. Thomas Lane will be presenting our collaborative work with Ohio State University as a poster.
“Machine learning models for predicting human liver microsomal metabolism of organophosphate pesticides”
Thomas Lane, Fabio Urbina, John Corbett, Kemal Ozalp, Garima Agarwal, Craig McElroy and Sean Ekins
Dr Ana Puhl will be presenting a talk “Applying Machine Learning For Antiviral Drug Discovery” at this meeting held at LOEWS CORONADO BAY RESORT, SAN DIEGO
We will be attending and contributing on an AI panel discussion
5.11.V-02 Machine Learning Models For Predicting Human Liver Microsomal Metabolism of Organophosphate Pesticides
Thomas Lane1, Fabio Urbina1, Garima Agarwal2, Craig McElroy2 and Sean Ekins1, (1)Collaborations Pharmaceuticals, Inc., (2)The Ohio State University
5.11.T-01 Comparisons of Biodegradation and Aquatic Toxicity Machine Learning Models
Thomas Lane, Fabio Urbina and Sean Ekins, Collaborations Pharmaceuticals, Inc.
Wednesday, November 16, 2022 10:00 AM
Convention Center - Ballroom B
Session: In silico NAMs: Recent developments and regulatory applications
5.11.V-04 Performance Comparison of Acetylcholinesterase Inhibition Machine Learning Models for Multiple Species
Patricia Vignaux, Fabio Urbina, Thomas Lane, Ana C Puhl, Sean Ekins and Jacob W Gerlach, Collaborations Pharmaceuticals, Inc.
Sheraton, Boston, MA
The Potential Dark Side of Generative AI for Drug Discovery
Boston Convention and Exhibition Center
Hot Topic: The Potential Dark Side of AI for Drug Discovery
Date: Tuesday October 18, 2022
Time: 2:30 PM-3:30 PM
Hot Topic Speaker
Spiez, Switzerland
We will presenting at the Spiez Convergence Conference on our recent dual use AI commentary.
This meeting will be held in Chicago and we will be presenting the following papers:
PAPER ID: 3754294
PAPER TITLE: Integrating computational, in vitro and in vivo approaches for SARS-CoV-2 drug discovery
DIVISION: Division of Chemical Information
SESSION: Chemoinformatics & COVID
SESSION TIME: 2:00 PM - 3:30 PM
PRESENTATION FORMAT: Oral - Hybrid
DAY & TIME OF PRESENTATION: Sunday, August 21, 2022 from 2:25 PM - 2:45 PM
ROOM & LOCATION: Glessner House B - Marriott Marquis Chicago
PAPER ID: 3753187
PAPER TITLE: Making the world aware of the potential dark side of generative AI for drug discovery
DIVISION: Division of Chemical Information
SESSION: Artificial Intelligence and Machine Learning with Publicly Available Chemical Data
SESSION TIME: 2:00 PM - 5:50 PM
PRESENTATION FORMAT: Oral - In-person
DAY & TIME OF PRESENTATION: Monday, August 22, 2022 from 2:05 PM - 2:30 PM
ROOM & LOCATION: Water Tower A - Marriott Marquis Chicago
Hynes Center, Boston, MA
We will presenting a pitch at the World Orphan Drug Congress meeting as well as a presentation on AI in Drug Discovery, given By Dr. Ana Puhl.
Dr. Sean Ekins will be presenting at the AI in Chemistry Workshop to be held in The Hague, The Netherlands.
